​​​Image of Shaf Keshavjee
Dr. Shaf Keshavjee is the Director of the Toronto Lung Transplant Program and UHN’s Surgeon-in-Chief. (Photo: UHN)​

Primary graft dysfunction (PGD) is a devastating form of acute lung injury that afflicts about 10-25 per cent of patients in the first hours to days after lung transplantation. It is the leading cause of death after transplant.

Although donor lungs are tested and examined before transplant, some signs of injury may not be able to be detected by standard tests.

University of Toronto and Toronto General Research Institute researchers have developed a microelectronic chip sensor which identifies, in minutes, whether a donor lung is at risk for PGD.

Researchers Drs. Shaf Keshavjee and Shana Kelley expect that this technology will be able to alert surgeons to damaged lungs which are not suitable for transplant, and may also reduce the numbers of lungs which are discarded but may have a good molecular profile.

“Currently, only about 15 per cent of all donated lungs are transplanted, leading to a shortage of lungs,” says Dr. Keshavjee, Director of the Toronto Lung Transplant Program and UHN Surgeon-in-Chief.

Read More

Wightman-Berris Academy Awards Ceremony

Mike Award

The Toronto Transplant Institute is proud to announce that Dr. Mike McDonald, Director of Education for the UHN Multi-Organ Transplant Program and Director of Education Toronto Transplant Institute was awarded the John W. Bradley Award for Educational Administration Innovation and Development.

Teachers and educators in all health professional disciplines form Mount Sinai, University Health Network, and our Community and Subspecialty Academy Sites were honoured on May 7, 2015.

The guest speaker, Ryan Brydges, Ph.D , Wilson Centre Scientist, presented a thought provoking talk on “The One Thing We’ll Never Stop Doing…Yet No One Teaches Us!” In it he challenged us as educators with trying to tackle the prospect of how we help develop the skills necessary for lifelong learning in our
trainees and in ourselves.